Abstract
The development and licensing of a vaccine for varicella in the United States has taken an incredible length of time. From the first report by Takahashi et al in 1974 until final American licensure in 1995, extensive studies were conducted by many investigators. Despite this long gestation period, which could have produced an elephant, there is some danger that the result will be a mouse, in that use of the vaccine since licensure has been far from universal. Recommendations by the American Academy of Pediatrics' Red Book Commitee and the Advisory Committee on Immunization Practices (statement in preparation, June 1995) may change that picture, but judging from conversations I have had, many American pediatricians have reservations concerning the varicella vaccine.
- Copyright © 1996 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- Uptake of Varicella Vaccination Among Young Children in the United States: A Success Story in Eliminating Racial and Ethnic Disparities
- Rapid Genotyping of Varicella-Zoster Virus Vaccine and Wild-Type Strains with Fluorophore-Labeled Hybridization Probes
- Improved Identification and Differentiation of Varicella-Zoster Virus (VZV) Wild-Type Strains and an Attenuated Varicella Vaccine Strain Using a VZV Open Reading Frame 62-Based PCR
- Varicella Vaccine Update
- A Long-term Prospective Study of Varicella Vaccine in Healthy Children